Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Invested Capital: 2019-2024

Historic Invested Capital for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $54.2 million.

  • Eton Pharmaceuticals' Invested Capital rose 28.83% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 28.83%. This contributed to the annual value of $54.2 million for FY2024, which is 160.05% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Invested Capital of $54.2 million as of FY2024, which was up 160.05% from $20.9 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Invested Capital peaked at $54.2 million during FY2024, and registered a low of $18.5 million during FY2022.
  • Its 3-year average for Invested Capital is $31.2 million, with a median of $20.9 million in 2023.
  • In the last 5 years, Eton Pharmaceuticals' Invested Capital dropped by 19.35% in 2022 and then soared by 160.05% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Invested Capital stood at $22.2 million in 2020, then rose by 3.14% to $22.9 million in 2021, then declined by 19.35% to $18.5 million in 2022, then grew by 12.97% to $20.9 million in 2023, then spiked by 160.05% to $54.2 million in 2024.